Meldungen aus Lausanne, Switzerland - San Francisco

10.01.2022 – 14:00
Debiopharm International SA
DEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
mehr
10.11.2021 – 08:00
Debiopharm International SA
Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
mehr